Boston Scientific Corporation Finds Clot Risk With Stent
NEW YORK, Sept 7 (Reuters) - Boston Scientific Corp. (BSX.N: Quote, Profile, Research) said on Thursday that a new internal analysis of its clinical data confirms an increased risk of blood clots with its drug-coated cardiac stent.